Interferon Alpha Therapy for Cervical CINI and HPV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

November 15, 2024

Study Completion Date

March 31, 2025

Conditions
Cervical DysplasiaHPV Infection
Interventions
DRUG

gel Interferon arm

0.2 ml gel interferon will be administered into vaginal using 1 ml syringe with measurement line. Patients will be trained how to fill the syringe and put into the vagina. Gel will be administered 2 times per day during the non menstruating day totally for 28 days.

DRUG

gel Interferon and interferon suppository arm

"0.2 ml gel interferon will be administered into vaginal using 1 ml syringe with measurement line. Patients will be trained how to fill the syringe and put into the vagina. Gel will be administered 2 times per day during the non menstruating day totally for 28 days.~3MIU suppository will be given to patients and will be trained how to use. Each patient in the arm will use the suppository twice a day for 10 days with vaginal therapy."

Trial Locations (1)

17011

National Cancer Center, Ulaanbaatar

All Listed Sponsors
collaborator

Mongolian National Cancer Center

UNKNOWN

lead

Mongolian National University of Medical Sciences

OTHER

NCT06137950 - Interferon Alpha Therapy for Cervical CINI and HPV Infection | Biotech Hunter | Biotech Hunter